- Home
- ASND vs FNF Comparison
ASND vs FNF Comparison
Compare ASND & FNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ASND | FNF |
|---|---|---|
| Founded | 2006 | 1847 |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.6B | 14.0B |
| IPO Year | 2014 | 2005 |
Fundamental Metrics
Financial Performance| Metric | ASND | FNF |
|---|---|---|
| Price | $239.04 | $47.78 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 2 |
| Target Price | ★ $279.50 | $62.50 |
| AVG Volume (30 Days) | 458.1K | ★ 1.9M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 4.35% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.21 |
| Revenue | N/A | ★ $14,445,000,000.00 |
| Revenue This Year | $97.60 | $11.41 |
| Revenue Next Year | $43.64 | $5.26 |
| P/E Ratio | ★ N/A | $21.61 |
| Revenue Growth | N/A | ★ 5.58 |
| 52 Week Low | $150.99 | $42.78 |
| 52 Week High | $248.60 | $65.33 |
Technical Indicators
Market Signals| Indicator | ASND | FNF |
|---|---|---|
| Relative Strength Index (RSI) | 59.39 | 51.03 |
| Support Level | $190.49 | $42.78 |
| Resistance Level | $248.60 | $60.63 |
| Average True Range (ATR) | 9.44 | 1.13 |
| MACD | 1.92 | 0.53 |
| Stochastic Oscillator | 76.67 | 90.07 |
Price Performance
Historical ComparisonAbout ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
About FNF FNF Group of Fidelity National Financial Inc.
Fidelity National Financial Inc is a provider of (i) title insurance, escrow and other title-related services, including trust activities, trustee sales guarantees, recordings and reconveyances and home warranty and (ii) transaction services to the real estate and mortgage industries. It operates in three segments: Title, F&G, Corporate and Other. The title segment that derives the majority of revenue consists of the operations of title insurance underwriters and related businesses, which provide title insurance and escrow and other title-related services including trust activities, trustee sales guarantees, and home warranty products. All of the company's revenue is generated in the United States.